A Simple Bedside Screening Tool for Spasticity Referral

Clin Interv Aging. 2020 May 13:15:655-662. doi: 10.2147/CIA.S248602. eCollection 2020.

Abstract

Background and objectives: Spasticity is common in long-term care facilities; however, this often-disabling condition is largely underdiagnosed in this setting and therefore left untreated. This study aimed to test the ability of a three-question flowchart used at the bedside by primary care providers in the long-term care setting to identify residents in need of referral to a specialist for spasticity consultation.

Methods: All residents of a single long-term care facility were approached for participation in this cross-sectional, observational study. Spasticity diagnostic evaluations by a movement disorders specialist neurologist (reference standard) were compared with referral determinations made by two primary care providers [a primary care physician (PCP) and a nurse practitioner (NP)] using the simple flowchart.

Results: The analysis included 49 residents (80% male, age 78.2±9.0 years) who were evaluated by the reference standard neurologist and at least one primary care provider. The bedside referral tool demonstrated high sensitivity and moderate specificity when used by the PCP (92% and 78%, respectively; AUC=0.84) and NP (80% and 53%, respectively; AUC=0.67).

Conclusion: This simple tool may be useful for primary care providers to identify residents to be referred to a specialist for evaluation and treatment of spasticity. These results warrant further investigation of the potential utility of this screening tool across multiple long-term care facilities and various types of care providers.

Keywords: long-term care; neurological disease; primary care; screening; spasticity.

MeSH terms

  • Aged
  • Cross-Sectional Studies
  • Diagnostic Errors / prevention & control
  • Female
  • Humans
  • Long-Term Care / methods*
  • Male
  • Mass Screening
  • Muscle Spasticity / diagnosis*
  • Nursing Homes
  • Point-of-Care Testing*
  • Referral and Consultation

Grants and funding

This work was supported by Ipsen Biopharmaceuticals, Inc. Ipsen had no input into study design, data collection, analysis, or interpretation or writing of the manuscript.